Literature DB >> 1379931

Specific binding sites for 125I-endothelin-1 in the porcine and human spinal cord.

M Niwa1, T Kawaguchi, A Himeno, M Fujimoto, M Kurihara, K Yamashita, Y Kataoka, K Shigematsu, K Taniyama.   

Abstract

Specific binding sites for 125I-endothelin-1 (125I-ET-1) in the spinal cord were investigated using quantitative receptor autoradiographic and chemical cross-linking methods. The binding sites were highly concentrated in porcine and human spinal cord areas corresponding anatomically to the dorsal horn (Rexed's laminae I-III), an area around the central canal (lamina X) and the principal part of the intermediolateral nucleus (IMLp). The localization of the binding sites differed from those of 125I-omega-conotoxin GVIA (125I-CgTx) and 125I-Bolton-Hunter substance P (125I-BH-SP), with the exception that the IMLp shared 125I-ET-1 with 125I-CgTx and 125I-BH-SP binding sites. Specific 125I-ET-1 binding sites in the areas examined were characteristically single and of high affinity. There were no differences between the potencies of unlabeled ET family peptides, ET-1, ET-2, ET-3 and sarafotoxin S6b at inhibiting 125I-ET-1 binding to the areas. Chemical cross-linking studies showed that 125I-ET-1 and 125I-ET-3 mainly bound to a protein with molecular mass of 43 kDa in the porcine and human thoracic spinal cord membranes. The present finding shows the neuronal significance of this newly discovered peptide in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379931     DOI: 10.1016/0922-4106(92)90101-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Involvement of glial endothelin/nitric oxide in delayed neuronal death of rat hippocampus after transient forebrain ischemia.

Authors:  K Yamashita; Y Kataoka; Y Sakurai-Yamashita; K Shigematsu; A Himeno; M Niwa; K Taniyama
Journal:  Cell Mol Neurobiol       Date:  2000-10       Impact factor: 5.046

2.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

3.  The endothelin ETA receptor exists in the caudal solitary tract nucleus of the rat brain.

Authors:  S Shibata; M Niwa; A Himeno; N G Gana; K Shigematsu; M Matsumoto; K Yamashita; K Sumikawa; K Taniyama
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

4.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

5.  Endothelin receptors in rat pituitary gland.

Authors:  S Shibata; A Himeno; K Shigematsu; K Tsutsumi; Y Sakurai-Yamashita; K Yamashita
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

6.  Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas.

Authors:  K Tsutsumi; N Kitagawa; M Niwa; S Yamaga; H Khalid; K Taniyama; A Himeno; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

7.  Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography.

Authors:  S Yamaga; K Tsutsumi; M Niwa; N Kitagawa; T Anda; A Himeno; H Khalid; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

8.  Endothelin-3 stimulates inositol 1,4,5-trisphosphate production and Ca2+ influx to produce biphasic dopamine release from rat striatal slices.

Authors:  Y Kataoka; S Koizumi; M Niwa; H Shibaguchi; K Shigematsu; Y Kudo; K Taniyama
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

9.  Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: histochemical evidence.

Authors:  K Yamashita; Y Kataoka; M Niwa; K Shigematsu; A Himeno; S Koizumi; K Taniyama
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

10.  A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.

Authors:  N Kitagawa; K Tsutsumi; M Niwa; S Yamaga; T Anda; H Khalid; A Himeno; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.